David L. Kuiper

Mr. Kuiper's experience includes advising:

• Actavis plc in connection with its US$25 billion acquisition of Forest Laboratories

• Questcor Pharmaceuticals in connection with its US$5.6 billion sale to Mallinckrodt PLC

• Ariosa Diagnostics in its acquisition by Roche

• Avanir Pharmaceuticals in its US$3.5 billion acquisition by Otsuka Pharmaceutical

• IsoTis OrthoBiologics in connection with the negotiation of private label supply and distribution agreements with various distributors in the US and internationally with respect to IsoTis' demineralized bone matrix products, which are regulated as medical devices and are subject to laws and international standards governing the use of human tissue

• VNUS Medical Technologies in connection with the negotiation of an international distribution agreement with Toray Industries, Inc. for clinical trial, supply and distribution of medical devices in Japan

• Biolase Technology, Inc. in connection with the establishment of a sales and support subsidiary in Seoul, South Korea, to expand penetration of the company’s dental lasers by providing service, education and technical support to the company's existing distributors in the Asia-Pacific region

• General Electric in connection with its worldwide license with Bionime, a global leader in biotechnology medical testing located in Taiwan, to develop, manufacture and market blood glucose monitoring systems

• Broadcom Corporation in connection with licensing and acquisitions of technology

• FX Online Japan KK in connection with an Application Services Agreement with Finatek LLC for use in Japan and other parts of Asia to manage foreign currency exchanges
• Agensys, Inc. in connection with co-development agreements and licenses with co-promotion options with Genentech, Merck, Seattle Genetics and Sanofi Aventis
• Allergan, Inc. in connection with long term supply and global marketing agreements with GlaxoSmithKline to develop and promote BOTOX® in Japan and China and in connection with intellectual property and commercial agreements required for the spin-off of Advanced Medical Optics

• Beckman Coulter in connection with its US$800 million acquisition of the life sciences diagnostic services business of a Japan-based manufacturer with operations in more than 100 countries
• Watson Pharmaceuticals in connection with licensing, manufacturing and development agreements in the United States and Japan and the divestiture of product lines in connection with its merger with Andrx Corporation
• Complete Production Services in connection with intellectual property issues in connection with its US$6.2 billion merger with Superior Energy Services
• Office Depot in negotiations with Christopher Lowell to design and distribute a line of Christopher Lowell office products and furnishings
• Mossimo in licensing and merchandising arrangements with Target Brands, Inc. and licensing agreements for eyewear
• Volcom in trademark licensing transactions in the US, Australia, Indonesia, South Africa and South America